An Extensive Method for Maintenance of Sterility in Mammalian Cell Culture Laboratory Routine

Cell culture laboratories are designed to secure sterile environments for biological studies, and its susceptibility to biological contaminants is a major problem for researchers. Contamination can generally be overcome by frequently disposing of contaminated materials, cleaning and maintaining the sanitation of working areas, but in some cases, it is hard to eradicate the source(s) of contaminating agents completely. In particular, mold and fungal-based contaminants could be a devastating problem for any laboratory. Therefore, various contamination types can repeat over time and result in an increasing problem in the lab. To control and eliminate possible contaminations, a periodic cleaning treatment with disinfectant materials should be a routine procedure of every specialized laboratory, regardless of the existence of any contamination. The conventional method for maintaining hygiene in cell culture laboratories is to clean all surfaces with 70% ethanol; however, this may not be the complete solution. This paper presents a short and easy way to check whether any contamination source(s) are present in laboratories. After identification of the most contaminant-rich areas, without any distinction, each laboratory surface where the culturing samples were taken was comprehensively treated with suggested concentrations of ethanol, sodium hypochlorite and Virkon-S solutions. The method might be useful to regularly check and maintain the cleanliness and hygiene of entire cell culture laboratories to enable the control of possible contaminations in advance

Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data

Background. We aimed to determine the number of cystic fibrosis (CF) patients recorded in the Cystic Fibrosis Registry of Türkiye (CFRT) who were in need of lung transplantation (LT) referral and examine clinical differences between patients who were LT candidates due to rapid forced expiratory volume in one second (FEV₁) decline and LT candidates without rapid FEV₁ decline in the last year to identify a preventable cause in patients with such rapid FEV₁ decline. Methods. All CF patients recorded in the CFRT in 2018 were evaluated in terms of LT. Patients were divided into those with FEV₁ below 50% and in need of LT due to a decrease of 20% or more in the previous year (Group 1) and those who did not have FEV₁ decline of more than 20% in the previous year but had other indications for LT (Group 2). Demographic and clinical features were compared between the two groups. Results. Of 1488 patients registered in CFRT, 58 had a need for LT. Twenty patients were included in Group 1 and others in Group 2. Our findings did not reveal any significant variations in treatment, chronic infection status, or complications between the two groups. The average weight z-score was significantly higher in Group 1. Positive correlations were detected between weight z-score and FEV₁ in 2017 in Group 1 and between FEV₁ values in 2017 and 2018 in Group 2. Conclusions. There appears to be a relationship between the nutritional status and weight z-scores of CF patients and pulmonary function, which may indirectly affect the need for lung transplantation referral

Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?

Background: Cystic fibrosis (CF) is an autosomal recessive disorder caused by CF transmembrane conductance regulator (CFTR) genetic variants. CFTR modulators improve pulmonary function and reduce respiratory infections in CF. This study investigated the clinical and laboratory follow-up parameters over 1 year in patients with CF who could not receive this treatment. Methods: This retrospective cohort study included 2018 and 2019 CF patient data from the CF registry of Turkey. Demographic and clinical characteristics of 294 patients were assessed, who had modulator treatment indications in 2018 but could not reach the treatment. Results: In 2019, patients younger than 18 years had significantly lower BMI z-scores than in 2018. During the 1-year follow-up, forced expiratory volumes (FEV1) and FEV1 z-scores a trend toward a decrease. In 2019, chronic Staphylococcus aureus colonization, inhaled antipseudomonal antibiotic use for more than 3 months, oral nutritional supplement requirements, and oxygen support need increased. Conclusions: Patients who had indications for modulator treatments but were unable to obtain them worsened even after a year of follow-up. This study emphasized the importance of using modulator treatments for patients with CF in our country, as well as in many countries worldwide